Candida pneumonia: Innocent colonizer or silent killer? A case report

Sergio G Monasterios-López, Martín A Ríos-Ayala, Carmen Hernández-Cárdenas, Gustavo Lugo-Goytia, Jaritzy G Lagunez Caramón

Abstract

Candida in tracheal aspirate is often classified as simple colonization or potentially fatal pulmonary infection. Fungal respiratory infections are of particular concern in the growing population of immunocompromised patients. Candida pneumonia is a rare and potentially fatal condition, with mortality rates reaching up to 70%. Demonstration of Candida species through lung biopsy along with evidence of inflammation is the only way to confirm this entity.

Keywords: Candida, Colonization, Pneumonia, Antifungal treatment, Acute respiratory failure.

References

1. Lamoth F, Alexander BD. Nonmolecular methods for the diagnosis of respiratory fungal infections. Clin Lab Med 2014; 34(2):315-336. https://doi.org/10.1016/j.cll.2014.02.006 PMid:24856530

2. Dermawan JKT, Ghosh S, Keating MK, et al. Candida pneumonia with severe clinical course, recovery with antifungal therapy and unusual pathologic findings: A case report. Medicine (Baltimore) 2018; 97(2):e9650. https://doi.org/10.1097/MD.0000000000009650 PMid:29480879 PMCid:PMC5943866

3. Lindau S, Nadermann M, Ackermann H, et al. Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects. J Intensive Care 2015; 3(1):31. https://doi.org/10.1186/s40560-015-0097-0 PMid:26146563 PMCid:PMC4490727

4. Tan M, Wang J, Hu P, et al. Severe pneumonia due to infection with Candida krusei in a case of suspected Middle East respiratory syndrome: A case report and literature review. Exp Ther Med 2016; 12(6):4085-4088. https://doi.org/10.3892/etm.2016.3892 PMid:28101187 PMCid:PMC5228306

5. Schnabel RM, Linssen CF, Guion N, et al. Candida pneumonia in intensive care unit? Open Forum Infect Dis 2014; 1(1):ofu026. https://doi.org/10.1093/ofid/ofu026 PMid:25734099 PMCid:PMC4324192

6. Albert M, Williamson D, Muscedere J, et al. Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo-controlled pilot trial (CANTREAT study). Intensive Care Med 2014; 40(9):1313-1322. https://doi.org/10.1007/s00134-014-3352-2 PMid:24981955

7. Meena DS, Kumar D. Candida Pneumonia: An innocent bystander or a silent killer? Med Princ Pract 2022; 31(1):98-102. https://doi.org/10.1159/000520111 PMid:34638123 PMCid:PMC8995637

8. McCarty TP, White CM, Pappas PG. Candidemia and invasive candidiasis. Infect Dis Clin North Am 2021; 35(2):389-413. https://doi.org/10.1016/j.idc.2021.03.007 PMid:34016283

9. Sobel JD, Vazquez J. Candidemia and systemic candidiasis. Semin Respir Infect 1990; 5(2):123-137.

10. Di Mango AL, Zanetti G, Penha D, et al. Endemic pulmonary fungal diseases in immunocompetent patients: an emphasis on thoracic imaging. Expert Rev Respir Med 2019; 13(3):263-277. https://doi.org/10.1080/17476348.2019.1571914 PMid:30668231

11. Su KC, Chou KT, Hsiao YH, et al. Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study. BMC Infect Dis 2017; 17(1):252. https://doi.org/10.1186/s12879-017-2364-2 PMid:28390391 PMCid:PMC5385026

12. F Lamoth, H Akan, D Andes, M Cruciani, O Marchetti, L Ostrosky-Zeichner, Z, Racil, C J Clancy, Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults. Clin Infect Dis 2021; 72(Suppl 2):S102-S108. https://doi.org/10.1093/cid/ciaa1943 PMid:33709130